Literature DB >> 23142292

Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells.

Jia Wu1, Xiaowei Ji, Linlin Zhu, Qiaoli Jiang, Zhenzhen Wen, Song Xu, Wei Shao, Jianting Cai, Qin Du, Yongliang Zhu, Jianshan Mao.   

Abstract

Abnormal cytokinesis increases the possibility of nuclear fusion in tumor cells. However, the role of microRNAs (miRNAs) in abnormal cytokinesis is unclear. Here, we found that miR-1290 was significantly up-regulated in clinical colon cancer tissues. Up-regulation of miR-1290 postponed cytokinesis and led to the formation of multinucleated cells. KIF13B was a target of miR-1290 that was involved in aberrant cytokinesis. Furthermore, enforced expression of miR-1290 activated the Wnt pathway and increased the reprogramming-related transcript factors c-Myc and Nanog. Our results suggest that up-regulation of miR-1290 in colon cancer cells impaired cytokinesis and affected reprogramming.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142292     DOI: 10.1016/j.canlet.2012.10.038

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  31 in total

1.  MicroRNA-mediated interacting circuits predict hypoxia and inhibited osteogenesis of stem cells, and dysregulated angiogenesis are involved in osteonecrosis of the femoral head.

Authors:  Gour-Shenq Kao; Yuan-Kun Tu; Pei-Hsun Sung; Feng-Sheng Wang; Yu-Der Lu; Chen-Ta Wu; Rio L C Lin; Hon-Kan Yip; Mel S Lee
Journal:  Int Orthop       Date:  2018-04-26       Impact factor: 3.075

2.  Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.

Authors:  Bo Sun; Nan Yang; Yao Jiang; Huifeng Zhang; Chunying Hou; Chao Ji; Yanyong Liu; Pingping Zuo
Journal:  Tumour Biol       Date:  2015-03-18

3.  Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer.

Authors:  C Yang; C Sun; X Liang; S Xie; J Huang; D Li
Journal:  Cancer Gene Ther       Date:  2016-03-11       Impact factor: 5.987

4.  MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.

Authors:  Ming Li; Xiao-Yan He; Zhi-Mei Zhang; Shuo Li; Li-Hua Ren; Ri-Sheng Cao; Ya-Dong Feng; Yin-Lin Ji; Ye Zhao; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

Review 5.  An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?

Authors:  Yoshinaga Okugawa; Yuji Toiyama; Ajay Goel
Journal:  Expert Rev Mol Diagn       Date:  2014-08-28       Impact factor: 5.225

6.  Profiling analysis of circulating microRNA expression in cervical cancer.

Authors:  Yuzo Nagamitsu; Hirotaka Nishi; Toru Sasaki; Yotaro Takaesu; Fumitoshi Terauchi; Keiichi Isaka
Journal:  Mol Clin Oncol       Date:  2016-04-25

7.  Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer.

Authors:  Luděk Záveský; Eva Jandáková; Vít Weinberger; Luboš Minář; Veronika Hanzíková; Daniela Dušková; Lenka Záveská Drábková; Iveta Svobodová; Aleš Hořínek
Journal:  Reprod Sci       Date:  2018-05-20       Impact factor: 3.060

Review 8.  MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.

Authors:  Ganji Purnachandra Nagaraju; Appiya Santharam Madanraj; Sheik Aliya; Balney Rajitha; Olatunji Boladale Alese; Ekamber Kariali; Afroz Alam; Bassel F El-Rayes
Journal:  Tumour Biol       Date:  2015-11-04

9.  miR-1290 is a potential prognostic biomarker in non-small cell lung cancer.

Authors:  Dongping Mo; Bing Gu; Xue Gong; Lei Wu; Hong Wang; Ye Jiang; Bingfeng Zhang; Meijuan Zhang; Yan Zhang; Jian Xu; Shiyang Pan
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

Review 10.  Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.

Authors:  Lingying Tong; Ye Yuan; Shiyong Wu
Journal:  Adv Drug Deliv Rev       Date:  2014-09-16       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.